MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy

被引：102

作者：

Kovacs, Kalman ^{[2
]}

Scheithauer, Bernd W. ^{[1
]}

Lombardero, Matilde ^{[3
]}

McLendon, Roger E. ^{[4
]}

Syro, Luis V. ^{[5
]}

Uribe, Humberto ^{[6
]}

Ortiz, Leon D. ^{[7
]}

Penagos, Luis C. ^{[8
]}

机构：

[1] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA

[2] Univ Toronto, St Michaels Hosp, Dept Pathol, Toronto, ON M5B 1W8, Canada

[3] Univ Santiago de Compostela, Dept Anat Vet Sci, Lugo, Spain

[4] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA

[5] Hosp Pablo Tobon Uribe, Dept Neurosurg, Medellin, Colombia

[6] Med Clin, Dept Neurosurg, Medellin, Colombia

[7] Inst Cancerol, Dept Neurosurg, Medellin, Colombia

[8] Med Clin, Dept Otolaryngol, Medellin, Colombia

来源：

ACTA NEUROPATHOLOGICA | 2008年 / 115卷 / 02期

关键词：

D O I：

10.1007/s00401-007-0279-5

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：261 / 262

页数：2

共 14 条

[1]

[Anonymous], US ENDOCR SOC

[2] Long-term response of pituitary carcinoma to temozolomide - Report of two cases [J].

Fadul, Camilo E. ;

Kominsky, Andrew L. ;

Meyer, Louise P. ;

Kingman, Linda S. ;

Kinlaw, William B. ;

Rhodes, C. Harker ;

Eskey, Clifford J. ;

Simmons, Nathan E. .

JOURNAL OF NEUROSURGERY, 2006, 105 (04) :621-626

[3]

Fadul CE, 2004, NEURO-ONCOLOGY, V6, P374

[4] DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to temodal in newly diagnosed malignant glioma [J].

Friedman, HS ;

McLendon, RE ;

Kerby, T ;

Dugan, M ;

Bigner, SH ;

Henry, AJ ;

Ashley, DM ;

Krischer, J ;

Lovell, S ;

Rasheed, K ;

Marchev, F ;

Seman, AJ ;

Cokgor, I ;

Rich, J ;

Stewart, E ;

Colvin, OM ;

Provenzale, JM ;

Bigner, DD ;

Haglund, MM ;

Friedman, AH ;

Modrich, PL .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) :3851-3857

[5] Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: morphological findings [J].

Kovacs, Kalman ;

Horvath, Eva ;

Syro, Luis V. ;

Uribe, Humberto ;

Penagos, Luis C. ;

Ortiz, Leon D. ;

Fadul, Camilo E. .

HUMAN PATHOLOGY, 2007, 38 (01) :185-189

[6] Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors [J].

Kulke, MH ;

Stuart, K ;

Enzinger, PC ;

Ryan, DP ;

Clark, JW ;

Muzikansky, A ;

Vincitore, M ;

Michelini, A ;

Fuchs, CS .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) :401-406

[7] Progressive low-grade oligodendrogliomas -: Response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression [J].

Levin, N ;

Lavon, I ;

Zelikovitsh, B ;

Fuchs, D ;

Bokstein, F ;

Fellig, Y ;

Siegal, T .

CANCER, 2006, 106 (08) :1759-1765

[8] Temozolomide: a novel treatment for pituitary carcinoma [J].

Lim, Stephen ;

Shahinian, Hrayr ;

Maya, Menahem M. ;

Yong, William ;

Heaney, Anthony P. .

LANCET ONCOLOGY, 2006, 7 (06) :518-520

[9]

McLendon RE, 1998, LAB INVEST, V78, P643

[10] Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors [J].

Möllemann, M ;

Wolter, M ;

Felsberg, J ;

Collins, VP ;

Reifenberger, G .

INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (03) :379-385

← 1 2 →